Chicago, IL -- (SBWIRE) -- 08/16/2013 -- PennyPicks.net prowls the markets, sifts through hundreds of companies and picks those positioned to move and then presents them to you. Stocks with the greatest possibility of gains, period. We call it as we see it and we are real about it. Let’s have a look at today’s hot stocks: Axa SA (ADR) (OTCMKTS:AXAHY), Montalvo Spirits Inc (OTCBB:TQLA), Affymax, Inc. (OTCMKTS:AFFY), KV Pharmaceutical Co (OTCMKTS:KVPHQ).
On Thursday, Axa SA (ADR) (OTCMKTS:AXAHY) gained volume of . 232,705 shares, while its average volume remained 119,643 shares. The stock was not a big volume gainer but a percentage gainer, as it grew +0.12% and closed the trading at $23.68. The day range of the stock remained $23.05 - $23.72.
What AXAHY’s Charts Are Signaling for Traders? Find Out Here
AXA Group, through its subsidiaries, provides insurance and asset management services.
Montalvo Spirits Inc (OTCBB:TQLA) traded with volume of 479,834 shares in the last session. The stock on Thursday decreased -9.91% to finish the day at $0.527. TQLA was a loser in the 6 month’s activity and plunged about -34.12%. The stock was a loser in its prior one month’s performance, as it showed a downward move of -24.71%.
How Should Investors Trade TQLA Now? Don’t Miss out a Special Trend Analysis
Montalvo Spirits, Inc., a development stage company, develops, markets, and distributes alcoholic beverages primarily in the United States. It offers its products primarily under the Montalvo Tequila brand name.
Affymax, Inc. (OTCMKTS:AFFY) traded with volume of 503,010 shares, while the average trading volume remained 1.14 million shares. AFFY showed a downward trend and on yesterday it stayed at -1.25% and finally closed the trading session at $1.58. The stock was a gainer in its prior one month’s performance, as it showed upward move of +31.67%.
Should AFFY a Buy or Sell Now? Find Out Here
Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
On Thursday, KV Pharmaceutical Co (OTCMKTS:KVPHQ) closed the trading session at the price of $0.190 and remained with positive change of +5.56%. Prior 5 days’ performance of the stock was negative, as it plunged -40.62% and the stock remained in bears in its preceding10 year’s performance, as it plunged -81.9%.
Is KVPHQ Buy After The Recent Price Movement? Find Out Here
K-V Pharmaceutical Company operates as a specialty branded pharmaceutical marketing company primarily focusing on women?s health care in the United States.
For the best penny stock picks penny stocks visit us at www.pennypicks.net
Our approach to penny stocks is completely different from most other sites out there. We prowl the markets, sift through hundreds of companies and pick those poised to move and then present them to you. Stocks with the greatest possibility of gains, period. We call it as we see it and we are real about it.
Please fully understand this disclaimer before using our site or joining our email list. If you have any questions please contact us at email@example.com
PennyPicks.net is a private membership service that specializes in providing opinions, comments and information on stocks to individuals who wish to receive them. Our reports are for information and entertainment purposes only and are distributed free of charge exclusively to individuals who wish to receive them.
Read More at: http://www.pennypicks.net/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)